Your browser is no longer supported. Please, upgrade your browser.
Settings
PLSE Pulse Biosciences, Inc. daily Stock Chart
PLSE [NASD]
Pulse Biosciences, Inc.
Index- P/E- EPS (ttm)-0.88 Insider Own23.30% Shs Outstand15.17M Perf Week6.12%
Market Cap413.08M Forward P/E- EPS next Y- Insider Trans37.05% Shs Float6.39M Perf Month14.46%
Income-11.00M PEG- EPS next Q- Inst Own3.40% Short Float24.90% Perf Quarter96.89%
Sales- P/S- EPS this Y-286.40% Inst Trans82.40% Short Ratio3.70 Perf Half Y355.35%
Book/sh1.98 P/B13.75 EPS next Y- ROA-38.40% Target Price- Perf Year-
Cash/sh1.25 P/C21.86 EPS next 5Y- ROE-39.80% 52W Range4.03 - 35.93 Perf YTD318.92%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-24.21% Beta-
Dividend %- Quick Ratio15.40 Sales past 5Y- Gross Margin- 52W Low575.68% ATR2.60
Employees11 Current Ratio15.40 Sales Q/Q- Oper. Margin- RSI (14)55.95 Volatility11.22% 9.68%
OptionableNo Debt/Eq0.00 EPS Q/Q-72.90% Profit Margin- Rel Volume0.38 Prev Close26.30
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout- Avg Volume429.72K Price27.23
Recom- SMA2010.29% SMA5012.36% SMA200142.99% Volume163,121 Change3.54%
May-07-17 10:39PM  Edited Transcript of PLSE earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-04-17 01:30PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
10:00AM  Investor Network: Pulse Biosciences, Inc. to Host Earnings Call Accesswire
Apr-17-17 06:34PM  Pulse Biosciences to Host Quarterly Investor Conference Call on May 4, 2017 Business Wire +10.06%
Mar-27-17 09:30AM  Xenon Pharmaceuticals Falls as Acne Drug Fails Study, Pulse Biosciences Submits 510(k) to FDA Accesswire +9.82%
Mar-26-17 10:25AM  Insider Buying Jumps as Market Volatility Grows: Sears, IFF, Pulse Biosciences, PRA Group, Radius Health and More
Mar-24-17 01:04PM  PULSE BIOSCIENCES, INC. Financials +17.19%
Mar-23-17 01:08PM  Insiders Load Up on Pulse Biosciences GuruFocus.com
Mar-20-17 05:17PM  PULSE BIOSCIENCES, INC. Files SEC form 10-K, Annual Report -5.96%
Mar-14-17 04:30PM  Pulse Biosciences Inc Earnings Call scheduled for 4:30 pm ET today
04:20PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
04:00PM  Pulse Biosciences Quartery Investor Conference Call Business Wire
08:30AM  Pulse Biosciences Submits 510(k) Application to FDA for PulseTx System Business Wire
07:07AM  Q4 2016 Pulse Biosciences Inc Earnings Release - Time Not Supplied
Mar-01-17 04:46PM  Pulse Biosciences to Host Investor Conference Call on March 14, 2017 Business Wire
Feb-23-17 01:11PM  StreetSweeper's New Short: Pulse Biosciences Benzinga
Feb-22-17 05:31PM  Heres where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars at bizjournals.com
05:31PM  Heres where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars American City Business Journals
Feb-21-17 05:13PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-10-17 09:24AM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S +23.84%
08:30AM  Pulse Biosciences Announces Healthcare Executives and Entrepreneurs Robert Duggan and Dr. Maky Zanganeh Have Acquired a Combined Interest of 17.1% of the Company Business Wire
Jan-27-17 03:53PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-14-16 04:01PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:00PM  Pulse Biosciences Quarterly Nano-Pulse Stimulation (NPS) Update Business Wire
08:00AM  Pulse Biosciences Announces First Clinical Use of the Proprietary PulseTx Platform in a Pilot Study in Dermatology Business Wire
Nov-11-16 08:00AM  Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits of Nano-Pulse Stimulation Technology Business Wire
Nov-02-16 03:00PM  Pulse Biosciences to Host Third Quarter Investor Conference Call on November 14, 2016 Business Wire
Oct-18-16 08:00AM  Pulse Biosciences to Present New Data at the Society for Immunotherapy in Cancer Annual Meeting Business Wire
Aug-24-16 04:00PM  Pulse Biosciences Appoints Edward Ebbers as Vice President and General Manager of Dermatology Products Business Wire
Pulse Biosciences, Inc., a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is based in Burlingame, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thaure Thierry B.DirectorMay 12Option Exercise2.6710,00026,70010,000May 12 06:17 PM
Thaure Thierry B.DirectorMay 12Sale24.4010,000244,0000May 12 06:17 PM
Zanganeh MakyDirectorMay 11Buy20.8415,000312,540278,935May 11 08:03 PM
DUGGAN ROBERT W10% OwnerMay 11Buy20.9617,600368,9223,026,316May 11 06:15 PM
Greenberg Robert J.DirectorMay 10Option Exercise2.6725,00066,75025,000May 10 07:55 PM
Zanganeh MakyDirectorMay 10Buy21.715,000108,54585,474May 11 08:03 PM
Greenberg Robert J.DirectorMay 10Sale21.1225,000528,1100May 10 07:55 PM
Zanganeh MakyDirectorMay 09Buy20.1633,760680,50080,474May 11 08:03 PM
DUGGAN ROBERT W10% OwnerMay 09Buy21.0925,789543,9673,008,716May 11 06:15 PM
Thaure Thierry B.DirectorMay 08Option Exercise2.6715,00040,05015,000May 10 05:58 PM
Thaure Thierry B.DirectorMay 08Sale22.4915,000337,3200May 10 05:58 PM
DUGGAN ROBERT W10% OwnerMay 02Buy23.405,000117,0002,982,927May 02 08:51 PM
DUGGAN ROBERT W10% OwnerMay 01Buy23.8119,348460,7152,977,927May 02 08:51 PM
DUGGAN ROBERT W10% OwnerApr 28Buy24.0035,000840,00035,000May 02 08:51 PM
DUGGAN ROBERT W10% OwnerApr 28Buy23.8525,000596,2502,958,579May 02 08:51 PM
DUGGAN ROBERT W10% OwnerApr 27Buy22.952004,5902,933,579Apr 27 09:14 PM
DUGGAN ROBERT W10% OwnerApr 26Buy24.4710,000244,6902,933,379Apr 27 09:14 PM
DUGGAN ROBERT W10% OwnerApr 25Buy24.9425,187628,1132,923,379Apr 27 09:14 PM
DUGGAN ROBERT W10% OwnerApr 19Buy23.77150,1233,567,7432,898,192Apr 19 07:54 PM
DUGGAN ROBERT W10% OwnerApr 18Buy25.4961,8191,576,0252,748,069Apr 19 07:54 PM
DUGGAN ROBERT W10% OwnerApr 17Buy24.81107,3002,661,9452,686,250Apr 19 07:54 PM
DUGGAN ROBERT W10% OwnerApr 10Buy21.1031,964674,5312,578,950Apr 10 09:43 PM
DUGGAN ROBERT W10% OwnerApr 07Buy19.5994,1001,843,7952,546,986Apr 10 09:43 PM
DUGGAN ROBERT W10% OwnerApr 06Buy19.3365,4001,263,9212,452,886Apr 10 09:43 PM
Zanganeh MakyDirectorMar 20Buy22.974,28098,30546,714Mar 20 09:48 PM
Zanganeh MakyDirectorMar 20Buy22.475,000112,360263,935Mar 20 09:48 PM
DUGGAN ROBERT W10% OwnerMar 18Buy23.01105,4862,427,1272,378,486Mar 20 09:50 PM
DUGGAN ROBERT W10% OwnerMar 17Buy24.0725,859622,4522,273,000Mar 20 09:50 PM
Zanganeh MakyDirectorMar 17Buy24.008,960215,00442,434Mar 20 09:48 PM
DUGGAN ROBERT W10% OwnerMar 16Buy24.1673,7821,782,3522,247,141Mar 20 09:50 PM
Zanganeh MakyDirectorFeb 15Buy11.9713,000155,64933,474Feb 22 02:48 PM
DUGGAN ROBERT W10% OwnerFeb 09Buy11.6441,624484,5032,173,359Feb 22 02:48 PM